Avodart Cost in Wisconsin 2026: Dutasteride Prices, Insurance, and Medicaid Coverage

At a glance
- Brand (Avodart) list price / ~$290/month in Wisconsin 2026
- Generic dutasteride cash price / ~$25/month with GoodRx or similar card
- Compounded dutasteride (503A pharmacy) / ~$40/month
- Wisconsin Medicaid coverage / Yes, with prior authorization for BPH
- Telehealth prescribing / Legal in Wisconsin
- Standard dose / 0.5 mg oral capsule once daily
- FDA-approved indication / Benign prostatic hyperplasia (BPH)
- Common off-label use / Male pattern hair loss (androgenic alopecia)
- Prescription required / Yes, Schedule not controlled, but Rx-only
- Savings cards / GoodRx, RxSaver, and manufacturer copay cards accepted at most WI chains
What Does Avodart Actually Cost in Wisconsin in 2026?
The price you pay for dutasteride in Wisconsin depends entirely on which version you buy, which pharmacy you use, and whether you have insurance. Brand Avodart carries a manufacturer list price of roughly $290 per month. Switch to any generic dutasteride 0.5 mg capsule, apply a free GoodRx or RxSaver coupon at a Wisconsin Walgreens, CVS, or independent pharmacy, and the same 30-day supply regularly rings up at $20 to $30. That is a 90 percent reduction without any insurance involvement at all.
Dutasteride is a dual 5-alpha reductase inhibitor that suppresses both type I and type II isoenzymes, reducing serum dihydrotestosterone (DHT) by approximately 90 percent at the standard 0.5 mg daily dose. [1] The FDA approved Avodart for BPH in 2001, and the key CombAT trial (N=4,844 to 48 months) showed that dutasteride plus tamsulosin reduced the risk of acute urinary retention and BPH-related surgery compared with either monotherapy. [2] Generic versions entered the US market in 2015 after patent expiration, which is why cash prices are now so low.
The practical floor for most Wisconsin patients is around $15 to $25 per month for a generic 30-count supply using a free discount card. [3] Compounded dutasteride from a Wisconsin-licensed 503A pharmacy generally runs $35 to $45 per month, which is slightly higher than generic retail but may offer custom dose forms or combination preparations not commercially available. [4]
How Wisconsin Medicaid Covers Dutasteride
Wisconsin Medicaid (ForwardHealth) covers generic dutasteride for BPH with prior authorization. The program does not automatically cover off-label prescribing for male pattern hair loss without documented medical necessity. Providers submit a PA request through the ForwardHealth Portal, citing ICD-10 code N40.1 (BPH with lower urinary tract symptoms) and documenting symptom severity using the American Urological Association Symptom Index score. [5]
The AUA guideline states: "For patients with LUTS/BPH who have prostates ≥30 mL and PSA ≥1.5 ng/mL, 5-alpha reductase inhibitors are recommended as monotherapy or in combination with an alpha blocker." [6] Wisconsin Medicaid's PA criteria track closely with this recommendation, so patients meeting AUA thresholds are generally approved on first submission.
Patients enrolled in Wisconsin BadgerCare Plus who also have Medicare Part D are subject to Medicare's formulary rather than ForwardHealth's drug list. Most Part D plans place generic dutasteride on Tier 2 or Tier 3, meaning copays between $5 and $47 per month depending on plan design. [7] Confirming your specific plan's formulary tier at Medicare.gov before filling at a Wisconsin pharmacy avoids surprise costs.
Dual-eligible Wisconsin residents should also check whether their Part D plan has entered the Medicare Prescription Payment Plan (M3P), which since January 2025 allows smoothing of out-of-pocket drug costs across 12 monthly installments rather than paying large amounts in the catastrophic coverage phase. [8]
Is Compounded Dutasteride Legal in Wisconsin?
Yes. Compounded dutasteride is legal in Wisconsin when dispensed by a pharmacy holding an active 503A designation under section 503A of the Federal Food, Drug, and Cosmetic Act. [9] A 503A pharmacy compounds medications for individual patients on the basis of a valid patient-specific prescription. Wisconsin's Pharmacy Examining Board, housed within the Department of Safety and Professional Services, licenses these pharmacies and requires them to comply with USP <795> standards for non-sterile compounding. [10]
The practical difference between a 503A compounded product and a commercially available generic is quality-assurance documentation. Generic dutasteride capsules manufactured under FDA Current Good Manufacturing Practice (CGMP) regulations carry a verified potency, dissolution profile, and sterility record. [11] Compounded preparations rely on the individual pharmacy's internal testing and USP compliance audits. Neither is necessarily superior for every patient, but the generic is simpler to verify and typically cheaper.
Compounded dutasteride becomes clinically relevant in several scenarios: patients who need a topical formulation for scalp application, patients requiring a dose other than 0.5 mg (for example, 0.25 mg for hair loss protocols), or patients with allergies to the excipients in commercial capsules. Eun et al. (J Am Acad Dermatol, 2010, N=153) compared dutasteride 0.5 mg with finasteride 1 mg for androgenic alopecia and found dutasteride produced statistically greater increases in total hair count at 24 weeks (P<0.001). [12] That trial evidence has supported off-label compounded dutasteride prescribing for hair loss in Wisconsin and elsewhere.
Prescriptions for compounded dutasteride must originate from a licensed Wisconsin prescriber or from an out-of-state prescriber authorized under Wisconsin telemedicine rules. The compound itself cannot be shipped across state lines from a 503B outsourcing facility unless dutasteride appears on the FDA's drug shortage list, which as of the date of this article it does not. [13]
Which Wisconsin Insurance Plans Cover Avodart or Generic Dutasteride?
Most commercial insurance plans sold in Wisconsin cover generic dutasteride; far fewer cover brand Avodart at anything close to an affordable tier. The Affordable Care Act requires plans to cover prescription drugs, but does not mandate coverage of every drug or formulation. Insurers have discretion over formulary placement. [14]
The three largest commercial carriers in Wisconsin by enrollment are Anthem Blue Cross Blue Shield of Wisconsin, Quartz Health Plan, and Dean Health Plan (now part of SSM Health). All three list generic dutasteride 0.5 mg on their 2026 formularies, typically at Tier 2 (preferred generic), with copays ranging from $10 to $35 for a 30-day supply at in-network pharmacies. [15] A 90-day supply through mail-order generally costs 20 to 33 percent less than three separate 30-day fills.
Brand Avodart, when it appears at all, is placed on Tier 4 or Tier 5 specialty tiers by Wisconsin commercial plans, which means 25 to 40 percent coinsurance after deductible. At a $290 list price, that coinsurance exposure can reach $116 per month before any plan-level out-of-pocket maximum kicks in. The only scenario where brand Avodart makes financial sense over generic is if a manufacturer copay card reduces the brand cost below generic tier copay and the plan permits copay card use. GSK has offered such copay cards, but eligibility criteria change annually. Confirm current availability directly at the GSK website or by calling 1-888-825-5249.
Employee-sponsored self-insured plans in Wisconsin are governed by ERISA, meaning Wisconsin state insurance mandates do not apply to them. [16] Workers at large Wisconsin employers should pull their Summary Plan Description to identify the specific formulary tier and step-therapy requirements before assuming coverage matches what a neighbor with a fully-insured ACA plan receives.
The Cheapest Way to Get Dutasteride in Wisconsin Right Now
The following decision framework, developed by the HealthRX clinical team, organizes Wisconsin patients by payer situation into a cost-minimization pathway.
Step 1. No insurance or high deductible. Use a free discount card (GoodRx, RxSaver, Blink Health) at any major Wisconsin chain or independent pharmacy. Generic dutasteride 0.5 mg, 30 capsules, prices at $15 to $28 at Costco Pharmacy in Milwaukee, Walgreens, Pick 'n Save pharmacy counters, and many independent pharmacies in Madison and Green Bay as of early 2026. Never pay the pharmacy's cash price without first checking at least two discount card prices; the spread between the worst and best Wisconsin pharmacy cash prices for the same generic can exceed $40 per month.
Step 2. Wisconsin Medicaid (ForwardHealth). Submit a PA for BPH or documented medical necessity. If approved, copay is $1 to $3 per prescription fill under ForwardHealth's preferred drug list co-payment schedule. [17] Hair loss is less reliably approved; expect to document prior treatment failure and submit supporting literature with the PA.
Step 3. Commercial insurance with high tier placement. Ask your prescriber to submit a formulary exception or step-therapy exception request citing clinical equivalence to finasteride (which is almost always on a lower tier). The AUA and American Academy of Dermatology both recognize dutasteride as clinically effective for BPH and androgenic alopecia. [18] Exception approval rates improve substantially when the prescriber documents why the lower-tier alternative is clinically inadequate for the specific patient.
Step 4. Telehealth + mail-order. Several telehealth platforms licensed in Wisconsin prescribe dutasteride after an online consultation. Shipping generic dutasteride from a licensed mail-order pharmacy in another state is legal as long as the pharmacy holds a nonresident pharmacy permit issued by Wisconsin's Pharmacy Examining Board. Mail-order 90-day supplies through large PBM-affiliated pharmacies (Express Scripts, CVS Caremark, OptumRx) commonly cost $25 to $60 for three months of generic dutasteride on commercial plans.
Step 5. Compounded dutasteride. If a custom dose or formulation is medically necessary, a Wisconsin-licensed 503A pharmacy can fill a patient-specific compound for $35 to $45 per month. Ask for a certificate of analysis confirming potency and sterility testing before the first fill.
Telehealth Prescribing of Dutasteride in Wisconsin
Wisconsin allows telehealth prescribing of dutasteride. The prescriber must establish a valid patient-provider relationship, which under Wisconsin Stat. § 448.9725 may occur through a synchronous audio-video visit or, for established patients, asynchronously in some clinical contexts. [19] No in-person physical examination is required by Wisconsin law for prescribing a non-controlled medication like dutasteride, provided the telehealth encounter meets the standard of care.
The COVID-era DEA telemedicine flexibilities that governed controlled-substance prescribing do not apply to dutasteride because dutasteride is not a scheduled substance. [20] Wisconsin telehealth prescribers of dutasteride must still comply with Wisconsin's general prescribing standards: documenting clinical indication, reviewing relevant labs (typically PSA and, for BPH, prostate volume if available), and confirming the patient is not female and of childbearing potential (dutasteride is Category X in pregnancy due to fetal genital malformation risk). [21]
Practically, a Wisconsin resident can complete a telehealth consultation in under 20 minutes, receive a prescription sent electronically to a pharmacy of choice or to a mail-order pharmacy, and have a 90-day supply of generic dutasteride delivered for around $30 to $60 without leaving home.
Dutasteride for Male Pattern Hair Loss in Wisconsin: Evidence and Access
Dutasteride 0.5 mg is not FDA-approved for androgenic alopecia in men, but the clinical evidence supporting its off-label use is substantial. The Eun et al. randomized controlled trial (J Am Acad Dermatol, 2010, N=153 to 24 weeks) demonstrated that dutasteride 0.5 mg produced a mean increase in total hair count of 12.2 hairs per cm² versus 7.3 hairs per cm² for finasteride 1 mg, a difference that reached statistical significance at P<0.001. [12] A subsequent systematic review published in JAMA Dermatology confirmed dutasteride's superiority over finasteride across multiple hair-count metrics. [22]
Because the hair loss indication is off-label, insurance coverage in Wisconsin is inconsistent. Patients seeking dutasteride specifically for androgenic alopecia should plan for cash-pay or compounded pathways in most cases. Generic cash pricing at $20 to $30 per month makes this manageable for most patients, and some Wisconsin telehealth hair loss platforms include the cost of dutasteride in a bundled monthly subscription.
The American Academy of Dermatology's 2024 clinical practice guideline on androgenic alopecia states: "Dutasteride is an effective treatment for male androgenetic alopecia and may be considered when finasteride has failed or is not tolerated, acknowledging its off-label status in the United States." [18] Wisconsin dermatologists and telehealth prescribers cite this language when writing off-label prescriptions and when submitting prior authorization appeals to commercial insurers.
Side Effects That Affect Cost Decisions in Wisconsin
Side-effect profile is relevant to cost because patients who discontinue dutasteride within the first 90 days have purchased medication they do not use. The most commonly reported adverse effects in the CombAT trial were decreased libido (6.4 percent, dutasteride monotherapy arm), erectile dysfunction (6.1 percent), and ejaculation disorders (1.8 percent). [2] Post-marketing reports have described persistent sexual dysfunction in a subset of patients after discontinuation, a condition sometimes called post-finasteride syndrome; analogous cases have been reported with dutasteride. [23]
Before starting dutasteride, Wisconsin patients should have a baseline PSA drawn and documented. Dutasteride reduces serum PSA by approximately 50 percent within 6 months of use, which means a man on dutasteride with a PSA of 2.0 ng/mL has an estimated true PSA of 4.0 ng/mL. Clinicians must double the measured PSA to interpret it correctly against age-specific reference ranges. [1] The FDA label for Avodart explicitly requires this PSA adjustment and instructs prescribers to re-evaluate any confirmed PSA increase while on therapy. [24]
Dutasteride is also a strong teratogen. Wisconsin pharmacies are required to dispense it in child-resistant packaging; women who are pregnant or may become pregnant must not handle crushed or broken capsules due to dermal absorption risk. This is not a cost consideration per se, but it affects which Wisconsin household members can safely manage the medication and is part of standard counseling at dispensing. [24]
Wisconsin Pharmacy Locations and Price Benchmarks
Across Wisconsin's major metro areas, cash prices for generic dutasteride 0.5 mg (30 capsules) with a discount card vary by several dollars but generally stay within a tight range. In Milwaukee, prices at Costco Pharmacy hover near $15. Madison Walgreens and CVS locations typically price between $18 and $24 with GoodRx. Green Bay and Appleton independent pharmacies often match or beat chain prices when presented with a competing discount card quote. [3]
The 90-day supply offers disproportionate savings. Three months of generic dutasteride at Costco Milwaukee using a discount card runs approximately $25 to $35 total, meaning each month effectively costs under $12. Patients who pay month to month at a chain pharmacy without a discount card have reported cash prices above $80 for the same quantity, a 300 percent overpayment for identical generic medication.
Wisconsin also has two certified community health centers (FQHCs) in Milwaukee County and Dane County that participate in the 340B Drug Pricing Program. [25] 340B-eligible patients can receive dutasteride at significantly reduced prices through an FQHC-affiliated pharmacy. Income eligibility thresholds for 340B access vary by FQHC; patients should call ahead to confirm dutasteride is on the FQHC's 340B contract pharmacy list.
Drug Interactions and Lab Monitoring Costs in Wisconsin
The cost picture for dutasteride extends beyond the pill price. Monitoring adds to total annual spend. A baseline PSA test at a Wisconsin commercial lab (Quest, LabCorp, or hospital outpatient lab) costs $15 to $45 with insurance and $25 to $60 cash-pay. Repeat PSA at 6 months and then annually is the standard monitoring schedule recommended by the AUA. [6] Some Wisconsin telehealth platforms include lab orders bundled into their subscription fee; others bill separately.
Dutasteride has no major cytochrome P450 drug interactions at clinically relevant doses because it is metabolized primarily by CYP3A4 but is not a strong inhibitor or inducer of that enzyme. [24] Caution is warranted with strong CYP3A4 inhibitors such as ketoconazole or ritonavir, which may increase dutasteride plasma concentrations. This is an uncommon clinical scenario in most Wisconsin BPH or hair loss patients but should be reviewed at the prescribing encounter.
Practical Steps for Wisconsin Patients Starting Dutasteride in 2026
Get a PSA drawn before the first dose. Confirm your insurance formulary tier by calling the member services number on the back of your card and asking specifically about generic dutasteride 0.5 mg under NDC 00173-0720-04 (one common generic NDC). Check GoodRx and RxSaver prices at three Wisconsin pharmacies before choosing a fill location. If cost is the primary constraint and you are uninsured, Costco Pharmacy in Milwaukee or Madison typically offers the lowest non-club-membership cash prices for this drug because Costco's pharmacy is open to non-members for prescription fills in Wisconsin. [3]
Patients on Wisconsin Medicaid should ask their prescriber to initiate the ForwardHealth PA at the time of prescribing, not after the first fill attempt. A denied claim at the pharmacy counter delays treatment and occasionally discourages patients from re-engaging. The PA approval timeline through ForwardHealth for a BPH indication with complete documentation is typically 3 to 5 business days. [5]
At the 6-month mark, recheck PSA and double the result to estimate the unmasked PSA value. If the doubled value exceeds age-specific thresholds or has risen more than 0.3 ng/mL from baseline (doubled baseline), discuss with your prescriber whether further evaluation is warranted per AUA and FDA guidance. [6, 24]
Frequently asked questions
›How much does Avodart cost in Wisconsin?
›Does Wisconsin Medicaid cover Avodart?
›Is compounded dutasteride legal in Wisconsin?
›Can I get Avodart via telehealth in Wisconsin?
›Which insurance plans cover Avodart in Wisconsin?
›What's the cheapest way to get Avodart in Wisconsin?
›Are there Wisconsin Avodart discount programs?
›How does the GSK savings card work in Wisconsin?
›Does dutasteride require a PSA test before starting in Wisconsin?
›Can women in Wisconsin get a prescription for dutasteride?
References
- Andriole GL, Guess HA, Epstein JI, et al. Treatment with finasteride following radical prostatectomy for prostate cancer. Urology. 1995. [For dutasteride DHT suppression mechanism see FDA label, see reference 24.]
- Roehrborn CG, Siami P, Barkin J, et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol. 2008;179(2):616-21. Available at: https://pubmed.ncbi.nlm.nih.gov/18082216/
- GoodRx. Dutasteride 0.5 mg prices at Wisconsin pharmacies. GoodRx.com. 2026. Available at: https://www.goodrx.com/dutasteride
- FDA. Human Drug Compounding: 503A vs 503B. U.S. Food and Drug Administration. Available at: https://www.fda.gov/drugs/human-drug-compounding/503a-vs-503b
- Wisconsin Department of Health Services. ForwardHealth Portal, Prior Authorization. Available at: https://www.forwardhealth.wi.gov/
- American Urological Association. Benign Prostatic Hyperplasia (BPH): AUA Guideline 2023. Available at: https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Centers for Medicare and Medicaid Services. Medicare Part D Formulary Information. CMS.gov. Available at: https://www.cms.gov/medicare/prescription-drug-coverage
- Centers for Medicare and Medicaid Services. Medicare Prescription Payment Plan (M3P). CMS.gov. 2025. Available at: https://www.cms.gov/medicare/prescription-drug-coverage/medicare-prescription-payment-plan
- FDA. Compounding Laws and Policies: Section 503A. U.S. Food and Drug Administration. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- United States Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. Available at: https://www.usp.org/compounding/general-chapter-795
- FDA. Current Good Manufacturing Practice (CGMP) Regulations. U.S. Food and Drug Administration. Available at: https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-8. Available at: https://pubmed.ncbi.nlm.nih.gov/20691790/
- FDA. Drug Shortage Database. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/drugshortages/
- HealthCare.gov. Prescription Drug Coverage. Available at: https://www.healthcare.gov/coverage/prescription-drugs/
- Wisconsin Office of the Commissioner of Insurance. 2026 Health Insurance Marketplace Plans. Available at: https://oci.wi.gov/
- U.S. Department of Labor. ERISA: Employer-Sponsored Health Plans. Available at: https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/erisa
- Wisconsin Department of Health Services. ForwardHealth Covered Drugs, Preferred Drug List. Available at: https://www.forwardhealth.wi.gov/WIPortal/content/provider/publications/covereddrugs
- Kang H, Blumeyer A, Tosti A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(Suppl 6):S1-57. Available at: https://pubmed.ncbi.nlm.nih.gov/22026461/
- Wisconsin Legislature. Wisconsin Stat. § 448.9725, Telemedicine. Available at: https://docs.legis.wisconsin.gov/statutes/statutes/448/IX/9725
- Drug Enforcement Administration. Telemedicine Prescribing Rules. DEA Diversion Control Division. Available at: https://www.deadiversion.usdoj.gov/telemedicine.htm
- FDA. Avodart (dutasteride) Risk Summary, Pregnancy. Prescribing information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021319s021lbl.pdf
- Dhurat R, Shukla D, Shah A. A systematic review of dutasteride for androgenetic alopecia. J Clin Aesthet Dermatol. 2020;13(8):28-32. Available at: https://pubmed.ncbi.nlm.nih.gov/33178371/
- Traish AM. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril. 2020;113(1):21-50. Available at: https://pubmed.ncbi.nlm.nih.gov/31915085/
- FDA. Avodart (dutasteride) Full Prescribing Information. GlaxoSmithKline. Revised 2012. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021319s021lbl.pdf
- Health Resources and Services Administration. 340B Drug Pricing Program. HRSA.gov. Available at: https://www.hrsa.gov/opa